[Pharmaceutical Bio News] Hyundai Bioscience to Begin Clinical Trials for Dengue Treatment in Vietnam on the 30th
Hyundai Bioscience is set to begin clinical trials for a universal antiviral treatment for dengue and similar diseases in Vietnam on March 30.
Alzheimer, Parkinson, aging... An infrared helmet to treat the brain, the astonishing bet of French researchers
French researchers at Clinatec are developing a non-invasive infrared light helmet to treat various brain and cardiovascular disorders, launching multiple clinical trials.
A stronger drug than oral Wigovi has been released... Global competition is intensifying
The global obesity drug market is rapidly shifting from injectable treatments to oral medications, marking a possible disruption to the dominance of Novo Nordisk and Eli Lilly.
Baldness: the molecule that 'awakens' dormant follicles and could regenerate hair growth
Researchers at the University of California have identified a molecule (PP405) that can reactivate inactive hair follicles, showing promising results in clinical trials for men experiencing hair loss.
Africa: Scientists Develop Treatment That Could Prevent Cervical Cancer
Scientists in Mexico have developed a new treatment using photodynamic therapy that successfully eliminates HPV, the primary cause of cervical cancer, in clinical trials with promising results.
Heart Failure, 5 Times Greater Risk in Some Cases: Women Most Affected
Women are significantly more affected by heart failure than men, particularly among older age groups, highlighting the need for more gender-specific medical research.
Africa: The Hunt for a New TB Vaccine - Why We Are Now So Close, and Why It Matters
Researchers in South Africa are making significant progress towards developing new tuberculosis vaccines, emphasizing the urgency given the ongoing toll of the disease.
Why Bayer chooses Argentina for science: the country concentrates 60% of its clinical trials in the region
Argentina hosts 60% of Bayer's regional clinical trials, reflecting significant investments in scientific capital.
'Rehabilitation is decisive and cannot be sidelined in studies with polylaminin,' says doctor
A Brazilian doctor emphasizes the importance of prioritizing rehabilitation in the clinical studies of polylaminin, a substance being tested for acute spinal cord injury treatment.
Danish pharmaceutical company punished on the stock exchange after weight loss data
Zealand Pharma's stock plummets nearly 30% following the release of disappointing weight loss trial results for its drug Petrilintid.
Hyundai BioScience launches global clinical trial for 'universal dengue treatment' in Vietnam
Hyundai BioScience has initiated a global clinical trial for a dengue and similar disease treatment in Vietnam, marking a significant step in addressing tropical infectious diseases with no existing effective treatments.
Scientists laud life-changing drug for children with resistant form of epilepsy
Scientists praise a promising new drug for treating children with Dravet syndrome, a severe form of epilepsy, following encouraging clinical trial results.
They measured whether weight loss injections impact men or women more and the result is surprising
A study by Johns Hopkins researchers found that weight loss injections are more effective in women than in men, based on a comprehensive analysis of clinical trials.
Race for polylaminin outside clinical studies raises alarm about application risks
There has been a surge of over 5,000 people seeking polylaminin from Cristália and the courts, raising concerns among neurosurgeons about the substance's safety due to unverified efficacy.
Hope for colorectal cancer patients as Nigeria begins immunotherapy trial
Nigeria has initiated immunotherapy trials aimed at providing promising treatment options for colorectal cancer patients.
FG confirms March arrival of HIV prevention injection
Nigeria is set to receive Lenacapavir, a significant HIV prevention injection, in March, which has shown 100% efficacy in clinical trials.
Paraguay announces retatrutida, but agency claims there is no authorization; drug is still in clinical study phase
A Paraguayan lab announced a drug for obesity treatment which lacks regulatory approval, as it is still in clinical trials despite promotional events.
Compensation for Patients with Prostate Cancer Begins
Lithuania starts compensating a medication for prostate cancer patients, which has shown to prolong survival, slow disease progression, and alleviate symptoms according to clinical trials.
New drug against HIV may revolutionize treatment in the elderly
A new daily single-dose pill for HIV treatment, BIC/LEN, has shown promise in clinical trials, simplifying the lives of long-term HIV patients.
Use of polylaminin is monitored in real time by society: 'Like a Big Brother', says researcher
Research on polylaminin, a substance being studied as a possible treatment for spinal cord injuries, is closely monitored by society, according to lead researcher Tatiana Sampaio.
South Africa: "Ethics, Trust, and the Future of Pediatric HIV Cure"
A recent webinar addressed the ethical and scientific considerations in pediatric HIV cure research, highlighting the role of people living with HIV in this field.
What do we know about Mazdutide, the medication with which you can lose up to 20 kilograms in a year?
Mazdutide, a weight-loss medication, shows significant weight loss results in a Chinese study, with participants losing an average of nearly 19% of their body weight over 48 weeks.
The first clinical trial to 'reprogram' human aging is launched
The first human clinical trial aimed at reversing aging processes has begun, announced by Dr. David Sinclair at the World Government Summit.
Research on new medications, such as polylaminin, must follow strict international rules
The development of new medications, including polylaminin, requires adherence to strict international guidelines, particularly in clinical trials that involve control groups to assess efficacy and safety.
Polylaminin is promising, but must overcome clinical trials
Polylaminin shows promise as a potential treatment for severe spinal injuries but faces significant challenges in clinical testing.
The increase in clinical trials in the EU will bring an additional 4 billion euros to healthcare systems
The European Commission and related organizations are striving to attract more clinical trials, which could generate additional funding and job creation in the healthcare sector.
Don't treat polylaminin as if it were the national team
The article discusses the recent hype surrounding polylaminin, a substance believed to regenerate spinal cord injuries, and its political implications in Brazil.
Neurologists alert to lack of evidence on the action of poly-L-lysine in spinal cord injury
Brazilian neurologists warn about insufficient scientific evidence supporting the use of poly-L-lysine for treating spinal cord injuries in humans.
Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is branded ‘obsolete’
Novo Nordisk's new weight-loss drug, CagriSema, has been deemed 'obsolete' after disappointing clinical trials, leading to a significant drop in the company's shares.
Problem with obesity drugs: patients lose too much weight, get scared, and stop taking them
A new obesity drug trial reveals significant weight loss but raises concerns as patients abandon the study due to fears of losing too much weight.
Alzheimer: Are Alzheimer drugs really not useful?
Experts from the Joint Federal Committee of Germany find no additional benefit for the Alzheimer drug Lecanemab compared to existing therapies.
Discover business models competing in the psychedelic market
Companies Cybin/Helus from Canada and Compass Pathways from the UK have reported promising data about psychedelics for depression.
Hope Against Triple Negative Breast Cancer: Experimental Vaccine Shows Positive Results
An experimental mRNA vaccine shows promising outcomes in a small trial for triple-negative breast cancer patients.
Let the death row inmates have hope.
A 62-year-old ALS patient in Norway describes her struggle to access life-prolonging medication after being denied participation in clinical trials and treatment options, highlighting the paradox of medical regulations.
"Hold on, this is what we were waiting for": Are the new clinical trials against baldness the dreamed revolution?
The clinical trials for PP405, a drug financed by Google aimed at treating androgenetic alopecia, have generated excitement among many men facing hair loss, though experts caution it is not yet a replacement for hair transplants.
'Tipping point' reached in creation of brain chips that can read thoughts
Researchers have reached a significant milestone in creating brain chips that can read thoughts, aiming to assist people with paralysis, with clinical trials set to begin soon.
Nipah virus vaccine from Japan set to begin clinical trials in April, promising prevention of the disease
A Japanese-developed Nipah virus vaccine is scheduled to begin clinical trials in Belgium in April, aiming to prevent the disease.
Moderna claims that the US refuses to review the mRNA-based flu vaccine
Moderna asserts that the US FDA has declined to review its mRNA-based flu vaccine due to concerns over inadequate clinical trials and lack of proper comparison with existing products.
Great Expectations for Vaccine Against Advanced Lung Cancer: What the Director of St. Savvas Oncology Says
The director of St. Savvas Oncology, Alexandros Ardavani, expresses optimism regarding an mRNA therapeutic vaccine currently undergoing trials for advanced lung cancer.
Scientists have a new idea for fighting depression. This method is a chance for many patients
Researchers propose a new approach to combat depression, particularly focusing on a subtype linked to immune system dysregulation, supported by recent clinical trial findings on anti-inflammatory treatments.
How the drugs that will revolutionize obesity treatment work
Semaglutide by Novo Nordisk is the first drug approved for obesity treatment that achieves weight loss comparable to bariatric surgery, while Eli Lilly's tirzepatide is expected to gain approval soon after showing efficacy and safety in clinical trials.
Day of Fight Against Cancer. Scientist: It is worth paying attention to what precedes clinical trials
The article discusses the increasing cancer challenges, focusing on the importance of understanding drug effectiveness before clinical trials, as cancer remains a leading cause of death in Poland.
A Spaniard leads a breakthrough that could accelerate the HIV vaccine
A Spanish scientist has made significant progress that could lead to accelerated development of an HIV vaccine, pending funding for human trials.
Mariano Barbacid against pancreatic cancer: the researcher and his team ask for help to start clinical trials
Mariano Barbacid and his team have developed a groundbreaking therapy that completely cured the most common form of pancreatic cancer in mice and are seeking assistance to begin clinical trials.
The new trends and the big gaps in clinical trials
Experts believe that the new Joint Ministerial Decision on clinical trials leaves significant gaps, which could hinder Greece's competitiveness in the international arena.
Podcast: the Brazilian experimental drug that may be hope for spinal cord injuries
The podcast discusses polylaminin, an experimental drug showing promise in restoring movement for patients with spinal cord injuries, highlighted by the case of a Brazilian influencer who regained arm movement after treatment.
A vaccine to prevent colon cancer shows promising results
A preventive vaccine, Nous-209, shows promising results in initial trials with patients at a significantly higher risk of developing tumors.
What health benefits do elderberry berries have?
Elderberry is known as a natural remedy for colds and flu, with some compounds possibly aiding blood pressure regulation, but current evidence is limited to laboratory and animal studies rather than human clinical trials, and raw elderberries can be toxic if not cooked properly.
From manned missions to the Moon to the treatment of rare diseases: The scientific milestones expected in 2026
The article discusses significant scientific milestones anticipated for 2026, including a manned Moon mission after 54 years, groundbreaking clinical trials, space missions, and major drilling projects.
Breakthrough report on ADHD. We know which therapies really work and which are a waste of time
A new umbrella review published in 'The BMJ' evaluates the effectiveness of various ADHD therapies based on a comprehensive analysis of clinical trials.